Squamous cell carcinoma of the temporal bone: the impact of local control on survival

被引:0
|
作者
Dubray-Vautrin, Antoine [1 ,2 ,3 ]
Verillaud, Benjamin [1 ,2 ]
Herman, Philippe [1 ,2 ]
Kania, Romain [1 ,2 ,4 ,5 ]
机构
[1] Univ Paris Cite, Lariboisiere Hosp, Assistance Publ Hop Paris, Dept Otorhinolaryngol Head & Neck Surg,Ctr Neurose, F-75010 Paris, France
[2] Platform Biopathol & Innovat Technol Hlth, UMR 1141 Ctr Developing Brain, Paris Biobank BB 0033 00064, Paris, France
[3] Inst Curie, Dept Otorhinolaryngol Head & Neck Surg, Paris, France
[4] Univ Paris Cite, Lariboisiere Hosp, Assistance Publ Hop Paris, Ctr Neurosensorial Head & Neck Dis,Dept Otorhinola, 2 Rue Ambroise Pare, F-75010 Paris, France
[5] Platform Biopathol & Innovat Technol Hlth, UMR 1141 Ctr Dev Brain, Paris Biobank BB 0033 00064, 2 Rue Ambroise Pare, F-00064 Paris, France
关键词
Temporal bone; squamous cell carcinomas; petrectomy; survival; local control; RADICAL SURGERY; TUMORS;
D O I
10.1080/00016489.2024.2311788
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Squamous cell carcinoma (SCC) of the temporal bone (TB) is a rare pathology originating from the external auditory canal (EAC). Surgery remains the gold standard to achieve local control.Aims/Objectives:The aim of this study was to evaluate overall survival (OS) and disease-free survival (DFS) after surgery of the SCC of EAC. Material and methodsA retrospective chart review in a tertiary referral center included 26 patients: 23 were operated with lateral temporal bone resection (LTBR, n = 10) and extended temporal bone resection (ETBR, n = 13). The outcomes were OS and DFS. Results Adjuvant radiotherapy was performed in 91.3% (n = 21/23). Mean age was 60.8 and sex ratio was 1. Median follow-up was 43 months; The 5-years OS was 90% (+/- 9.5%) and 47.7% (+/- 12.9%) for stage I/II and III/IV respectively (p = .033). DFS was 67.6% (IC 95%, 51.4%-88.9%) without statistical difference between early advanced stage. Incomplete margins (p = .004) and Stage IV(p < .001) were associated with poorer DFS. Free margins significantly correlated with better OS (HR = 9.8, p = .04). Conclusion En bloc surgical resection with free margins, coupled with postoperative radiotherapy, provides optimal local control. For stage IV tumors, where complete margins are achievable, ETBR is recommended to enhance local control.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [41] Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse
    Liu, Shih-An
    Wong, Yong-Kie
    Lin, Jin-Ching
    Poon, Chiu-Kwan
    Tung, Kwong-Chung
    Tsai, Wen-Chen
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 136 (01) : 112 - 118
  • [42] The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy
    Nathu, RM
    Mancuso, AA
    Zhu, TC
    Mendenhall, WM
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2000, 22 (01): : 1 - 5
  • [43] The Role of Facial Palsy in Staging Squamous Cell Carcinoma of the Temporal Bone and External Auditory Canal: A Comparative Survival Analysis
    Higgins, Thomas S.
    Antonio, Stephanie A. Moody
    OTOLOGY & NEUROTOLOGY, 2010, 31 (09) : 1473 - 1479
  • [44] Nodal disease in temporal bone squamous carcinoma
    Rinaldo, A
    Ferlito, A
    Suárez, C
    Kowalski, LP
    ACTA OTO-LARYNGOLOGICA, 2005, 125 (01) : 5 - 8
  • [45] SQUAMOUS CARCINOMA OF THE TEMPORAL BONE - A REVISED STAGING
    CLARK, LJ
    NARULA, AA
    MORGAN, DAL
    BRADLEY, PJ
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1991, 105 (05): : 346 - 348
  • [46] Squamous Cell Carcinoma of the Temporal Bone: Outcomes of Radical Surgery and Postoperative Radiotherapy
    Leong, Samuel C.
    Youssef, Ahmed
    Lesser, Tristram H.
    LARYNGOSCOPE, 2013, 123 (10): : 2442 - 2448
  • [47] Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone
    Yosuke Kitani
    Akira Kubota
    Madoka Furukawa
    Kaname Sato
    Yuko Nakayama
    Tetsuo Nonaka
    Nobutaka Mizoguchi
    European Archives of Oto-Rhino-Laryngology, 2016, 273 : 1293 - 1298
  • [48] Cetuximab with radiotherapy as an alternative treatment for advanced squamous cell carcinoma of the temporal bone
    Ebisumoto, Koji
    Okami, Kenji
    Hamada, Masashi
    Maki, Daisuke
    Sakai, Akihiro
    Saito, Kosuke
    Shimizu, Fukuko
    Kaneda, Shoji
    Iida, Masahiro
    AURIS NASUS LARYNX, 2018, 45 (03) : 637 - 639
  • [49] Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone
    Kitani, Yosuke
    Kubota, Akira
    Furukawa, Madoka
    Sato, Kaname
    Nakayama, Yuko
    Nonaka, Tetsuo
    Mizoguchi, Nobutaka
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2016, 273 (05) : 1293 - 1298
  • [50] Therapeutic effect of Nivolumab for advanced/recurrent temporal bone squamous cell carcinoma
    Noda, Teppei
    Komune, Noritaka
    Yasumatsu, Ryuji
    Tsuchihashi, Nana Akagi
    Tamae, Akihiro
    Matsumoto, Nozomu
    Sato, Kuniaki
    Uchi, Ryutaro
    Koike, Kensuke
    Wakasaki, Takahiro
    Tanaka, Risa
    Nakagawa, Takashi
    AURIS NASUS LARYNX, 2020, 47 (05) : 864 - 869